CALTX — Calliditas Therapeutics AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareMid Cap

Annual balance sheet for Calliditas Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	754	996	956	1,249	974
Net Total Accounts Receivable
Net Total Receivables	49.3	22.8	11.3	81	188
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	821	1,037	1,013	1,412	1,275
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.06	5.41	39.6	31.9	54.2
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	845	1,506	1,460	1,953	1,859
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	53.4	106	135	325	407
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	57.1	296	452	1,187	1,524
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	788	1,210	1,008	766	335
Total Liabilities & Shareholders' Equity	845	1,506	1,460	1,953	1,859
Total Common Shares Outstanding